RORA, one of the circadian genes, inhibited tumorigenesis and progression in various tumors, including breast cancer [44], prostate cancer [45, 46], lung carcinoma [45, 47], endometrial cancer [48], and gastric cancer [49]. This evidence concerns the gene RORA and breast carcinoma.